Skip to main content
News, talk and articles

The latest news from PTC

  1. PTC in 2021: A Year of Expansion

    For PTC, 2021 was about expansion – not just literally, as we grew our global reach and added team members, but what we can do for patients, too, through our awareness efforts and continued dedication to scientific innovation. Expansion by definition is the act of becoming larger or more extensive. And in fact, we had so much good news in 2021, it was hard for us to pick the highlights to include…
    Business & Finance, Our Culture, Rare Disease Community, Responsibility, Science & Innovation
    December 22, 2021
    3 minutes
  2. Phase 2/3 Clinical Trial to Evaluate Potential COVID-19 Treatment

    The U.S. Food and Drug Administration has authorized the initiation of a Phase 2/3 trial to investigate PTC299, a dihydroorotate dehydrogenase (DHODH) inhibitor, as a potential treatment for COVID-19. PTC299 is an oral investigational drug with a novel dual-mechanism of action that has the potential to address the two critical elements of COVID-19: High viral…
    Science & Innovation
    June 17, 2020
    1 minute